Skip to Main Content

As anger rose over prescription drug prices, two Washington lawmakers criticized drug makers for taking advantage of Americans, but wanted numbers to back up their claims. Now a new government report, which they requested, provide those numbers — and also potential ammunition in the fight over drug prices.

From 2006 to 2015, global sales for the pharmaceutical industry, including biotech companies, jumped 45 percent to $775 billion. Two-thirds of all drug makers experienced rising profit margins, which averaged 17 percent in 2015. And from 2008 through 2014, worldwide R&D spending — most of which went to drug development, rather than research — increased 8.5 percent, to $89 billion.


In short, the industry was pocketing more money while prices were either rising for many medicines or high prices were set for new treatments, but R&D funding increased only slightly, according to the report by the U.S. Government Accountability Office. The report was requested by U.S. Sen. Bernie Sanders (I-Vt.) and U.S. Rep. Elijah Cummings (D-Md.).

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!